Disease-free survival as a predictor of overall survival in localized renal cell carcinoma (RCC) following first nephrectomy.

被引：5
|
作者：
Haas, Naomi B.
Song, Yan
Rogerio, Jaqueline Willemann
Zhang, Su
Adejoro, Oluwakayode
Carley, Christopher
Zhu, Jingjing
Bhattacharya, Rituparna
Signorovitch, James
Sundaram, Murali
机构：
[1] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Anal Grp Inc, Boston, MA USA
[3] Merck & Co Inc, Kenilworth, NJ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.4581
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4581
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Renal Cell Carcinoma Improves cytoreductive Nephrectomy Overall Survival?
    Post, Antonie
    AKTUELLE UROLOGIE, 2015, 46 (02) : 101 - 101
  • [22] A Novel Predictor of Survival with Renal Cell Carcinoma After Nephrectomy
    Peng, Ding
    He, Zhi-song
    Li, Xue-song
    Tang, Qi
    Zhang, Lei
    Yan, Kai-wei
    Yu, Xiao-teng
    Zhang, Cui-jian
    Zhou, Li-qun
    JOURNAL OF ENDOUROLOGY, 2017, 31 (04) : 397 - 404
  • [23] Pazopanib exposure response assessment as adjuvant therapy for patients with localized or locally advanced renal cell carcinoma (RCC) following nephrectomy.
    Sternberg, Cora N.
    Donskov, Frede
    Haas, Naomi B.
    Doehn, Christian
    Russo, Paul
    Elmeliegy, Mohamed
    Banerjee, Hiya
    Aimone, Paola
    Voi, Maurizio
    Motzer, Robert J.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [24] Immunoreactivity for ubiquitin is an independent predictor of survival in renal cell carcinoma (RCC).
    Karikehalli, S
    Kallakury, BVS
    Sheehan, CE
    Azumi, N
    Fisher, HAG
    Kaufman, RP
    Ross, JS
    LABORATORY INVESTIGATION, 2001, 81 (01) : 113A - 113A
  • [25] Disease-free survival (DFS) as a surrogate for overall survival (OS) in localized prostate cancer (CaP).
    Sweeney, Christopher
    Xie, Wanling
    Regan, Meredith M.
    Nakabayashi, Mari
    Buyse, Marc E.
    Clarke, Noel W.
    Collette, Laurence
    Dignam, James J.
    Fizazi, Karim
    Habibian, Muriel
    Halabi, Susan
    Kantoff, Philip W.
    Parulekar, Wendy R.
    Sandler, Howard M.
    Sartor, Oliver
    Soule, Howard R.
    Sydes, Matthew Robert
    Tombal, Bertrand F.
    Williams, Scott G.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Immunoreactivity for ubiquitin is an independent predictor of survival in renal cell carcinoma (RCC).
    Karikehalli, S
    Kallakury, BVS
    Sheehan, CE
    Azumi, N
    Fisher, HAG
    Kaufman, RP
    Ross, JS
    MODERN PATHOLOGY, 2001, 14 (01) : 113A - 113A
  • [27] Analysis of mutational status in recurrently mutated genes in clear cell renal cell carcinoma and overall survival in patients with metastatic disease at time of nephrectomy.
    Manley, Brandon
    Casuscelli, Jozefina
    Tennenbaum, Daniel
    Hakimi, A. Ari
    Hsieh, James
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [28] Use of preoperative erythrocyte sedimentation rate (ESR) to predict overall survival in localized renal cell carcinoma following radical nephrectomy
    Master, V. A.
    Kucuk, O.
    Harris, W.
    Cross, B.
    Abbasi, A.
    Michigan, A.
    DeRosa, A.
    Johnson, T. V.
    Marshall, F. F.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [29] CONDITIONAL DISEASE-FREE SURVIVAL IN HIGH RISK LOCALIZED RENAL CELL CARCINOMA TREATED WITH OR WITHOUT ADJUVANT SUNITINIB
    Shao, Ning
    Qu, Yuan
    Wan, Fang
    Ye, Ding
    JOURNAL OF UROLOGY, 2019, 201 (04): : E342 - E342
  • [30] Metastatic renal cell carcinoma in a child: 11-year disease-free survival following surgery
    Grant, R
    Trevenen, C
    Hyndman, WC
    Rubin, SZ
    Coppes, MJ
    MEDICAL AND PEDIATRIC ONCOLOGY, 1997, 28 (03): : 201 - 204
12345